NCT02624050

Brief Summary

Patient undergoing general anesthesia in elective surgery will be assigned to receive either methohexital or propofol general anesthesia. Hypotensive events during the first 15 minutes of induction will be compared between the groups to ascertain which drug is less likely to cause a hypotensive event.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 8, 2015

Completed
8 months until next milestone

Study Start

First participant enrolled

August 1, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 13, 2019

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

December 3, 2015

Results QC Date

January 20, 2019

Last Update Submit

January 15, 2025

Conditions

Keywords

ACEIARBHypotensionGeneral AnesthesiaMethohexitalPropofol

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Had Hypotensive Events

    Hypotensive events under either methohexital or propofol general anesthesia will be counted as the primary outcome measure

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

Secondary Outcomes (10)

  • Number of Participants With Refractory Hypotension

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

  • Duration of Each Hypotension Episode

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

  • Systolic Blood Pressure

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

  • Diastolic Blood Pressure

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

  • Heart Rate

    Hemodynamic measurements will be taken during the first 15 minutes of anesthetic induction

  • +5 more secondary outcomes

Study Arms (2)

Methohexital

ACTIVE COMPARATOR

Methohexital will be administered intravenously as a general anesthetic at a dosage of 1.5mg per kg of patient body weight.

Drug: Methohexital

Propofol

ACTIVE COMPARATOR

Propofol will be administered intravenously as a general anesthetic at a dosage of 2.5mg per kg of patient body weight.

Drug: Propofol

Interventions

Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event.

Also known as: Brevital
Methohexital

Both drugs of interest are standard of care for use as general anesthetics. The purpose of the study is the determine the susceptibility of both drugs to inducing a hypotensive event.

Also known as: Diprivan
Propofol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • treated for at least 6 weeks with ACEIs or ARB
  • undergoing elective surgery under general endotracheal anesthesia
  • ASA Physical Class I or II

You may not qualify if:

  • BMI \>45kg/m\^2
  • taking both ACEI and ARB
  • history of difficult intubation in the past
  • require rapid sequence induction and intubation
  • uncontrolled baseline blood pressure (SBP\>180mmHg or DBP \>110 mmHg) at anesthesia preoperative clinic visit
  • contraindication to the use of propofol or methohexital
  • significant coronary artery disease
  • history of systolic heart failure
  • history of renal failure (creatine level \>2 mg/dL)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Milton S Hershey Medical Ctr

Hershey, Pennsylvania, 17036, United States

Location

Related Publications (12)

  • Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001 Jan;92(1):26-30. doi: 10.1097/00000539-200101000-00006.

    PMID: 11133595BACKGROUND
  • Carter JA, Clarke TN, Prys-Roberts C, Spelina KR. Restoration of baroreflex control of heart rate during recovery from anaesthesia. Br J Anaesth. 1986 Apr;58(4):415-21. doi: 10.1093/bja/58.4.415.

    PMID: 3954922BACKGROUND
  • Cullen PM, Turtle M, Prys-Roberts C, Way WL, Dye J. Effect of propofol anesthesia on baroreflex activity in humans. Anesth Analg. 1987 Nov;66(11):1115-20.

    PMID: 3499095BACKGROUND
  • Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992 May;76(5):725-33. doi: 10.1097/00000542-199205000-00010.

    PMID: 1575340BACKGROUND
  • Eyraud D, Brabant S, Nathalie D, Fleron MH, Gilles G, Bertrand M, Coriat P. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg. 1999 May;88(5):980-4. doi: 10.1097/00000539-199905000-00003.

    PMID: 10320155BACKGROUND
  • Giudicelli JF, Berdeaux A, Edouard A, Richer C, Jacolot D. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol. 1985 Sep;20(3):211-8. doi: 10.1111/j.1365-2125.1985.tb05063.x.

    PMID: 2994702BACKGROUND
  • Gold MI, Abraham EC, Herrington C. A controlled investigation of propofol, thiopentone and methohexitone. Can J Anaesth. 1987 Sep;34(5):478-83. doi: 10.1007/BF03014354.

    PMID: 3499244BACKGROUND
  • Komatsu R, You J, Mascha EJ, Sessler DI, Kasuya Y, Turan A. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg. 2013 Dec;117(6):1329-37. doi: 10.1213/ANE.0b013e318299a516.

    PMID: 24257383BACKGROUND
  • Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963-74.

    PMID: 7168798BACKGROUND
  • Mets B. Management of hypotension associated with angiotensin-axis blockade and general anesthesia administration. J Cardiothorac Vasc Anesth. 2013 Feb;27(1):156-67. doi: 10.1053/j.jvca.2012.06.014. Epub 2012 Jul 31. No abstract available.

    PMID: 22854335BACKGROUND
  • Nielson E, Hennrikus E, Lehman E, Mets B. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery. J Hosp Med. 2014 May;9(5):283-8. doi: 10.1002/jhm.2155. Epub 2014 Jan 24.

    PMID: 24464761BACKGROUND
  • Price ML, Millar B, Grounds M, Cashman J. Changes in cardiac index and estimated systemic vascular resistance during induction of anaesthesia with thiopentone, methohexitone, propofol and etomidate. Br J Anaesth. 1992 Aug;69(2):172-6. doi: 10.1093/bja/69.2.172.

    PMID: 1389822BACKGROUND

MeSH Terms

Conditions

Hypotension

Interventions

MethohexitalPropofol

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

BarbituratesPyrimidinonesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Results Point of Contact

Title
Dr. Anthony Bonavia
Organization
Milton S. Hershey Medical Center

Study Officials

  • Anthony Bonavia, MD

    Milton S. Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 3, 2015

First Posted

December 8, 2015

Study Start

August 1, 2016

Primary Completion

January 31, 2018

Study Completion

January 31, 2018

Last Updated

January 28, 2025

Results First Posted

March 13, 2019

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations